These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 15995158)

  • 1. Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma.
    Jeffreys AB; Knapp DW; Carlton WW; Thomas RM; Bonney PL; Degortari A; Lucroy MD
    J Am Anim Hosp Assoc; 2005; 41(4):221-6. PubMed ID: 15995158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
    Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
    J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
    Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
    Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs.
    Zenker I; Meichner K; Steinle K; Kessler M; Hirschberger J
    Vet Rec; 2010 Nov; 167(19):744-8. PubMed ID: 21257510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asparaginase and MOPP treatment of dogs with lymphoma.
    Brodsky EM; Maudlin GN; Lachowicz JL; Post GS
    J Vet Intern Med; 2009; 23(3):578-84. PubMed ID: 19645842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy with L-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma.
    Saba CF; Thamm DH; Vail DM
    J Vet Intern Med; 2007; 21(1):127-32. PubMed ID: 17338160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with continuous L-asparaginase, lomustine, and prednisone for relapsed canine lymphoma.
    Saba CF; Hafeman SD; Vail DM; Thamm DH
    J Vet Intern Med; 2009; 23(5):1058-63. PubMed ID: 19678892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
    Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
    J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of canine lymphoma with COPLA/LVP.
    Boyce KL; Kitchell BE
    J Am Anim Hosp Assoc; 2000; 36(5):395-403. PubMed ID: 10997514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma.
    Simon D; Moreno SN; Hirschberger J; Moritz A; Kohn B; Neumann S; Jurina K; Scharvogel S; Schwedes C; Reinacher M; Beyerbach M; Nolte I
    J Am Vet Med Assoc; 2008 Mar; 232(6):879-85. PubMed ID: 18341445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent use of rabacfosadine and L-asparaginase for relapsed or refractory multicentric lymphoma in dogs.
    Cawley JR; Wright ZM; Meleo K; Post GS; Clifford CA; Vickery KR; Vail DM; Bergman PJ; Thamm DH
    J Vet Intern Med; 2020 Mar; 34(2):882-889. PubMed ID: 32064697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma.
    Moore AS; Cotter SM; Rand WM; Wood CA; Williams LE; London CA; Frimberger AE; L'Heureux DA
    J Vet Intern Med; 2001; 15(4):348-54. PubMed ID: 11467592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
    Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
    J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early progression during or after cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy indicates poor outcome with rescue protocols in dogs with multicentric lymphoma.
    Parker AS; Burton JH; Curran KM; Wolf-Ringwall A; Thamm DH
    J Vet Intern Med; 2024; 38(4):2282-2292. PubMed ID: 38961691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the results of a L-asparaginase-based continuous chemotherapy protocol versus a short doxorubicin-based induction chemotherapy protocol in dogs with malignant lymphoma.
    Piek CJ; Rutteman GR; Teske E
    Vet Q; 1999 Apr; 21(2):44-9. PubMed ID: 10321012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases.
    Sorenmo K; Overley B; Krick E; Ferrara T; LaBlanc A; Shofer F
    Vet Comp Oncol; 2010 Sep; 8(3):196-208. PubMed ID: 20691027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma.
    Burton JH; Garrett-Mayer E; Thamm DH
    Vet Comp Oncol; 2013 Dec; 11(4):306-15. PubMed ID: 22548975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma.
    Siedlecki CT; Kass PH; Jakubiak MJ; Dank G; Lyons J; Kent MS
    Can Vet J; 2006 Jan; 47(1):52-9. PubMed ID: 16536229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of a cyclic combination chemotherapeutic protocol on primary haemostasis in dogs suffering from malignant lymphoma.
    Eberle N; Mischke R
    Vet J; 2010 Mar; 183(3):298-304. PubMed ID: 19185520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol.
    Simon D; Nolte I; Eberle N; Abbrederis N; Killich M; Hirschberger J
    J Vet Intern Med; 2006; 20(4):948-54. PubMed ID: 16955821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.